Search - tctmd.com

Displaying 901 - 920 of 1033

Sort: Relevancy | Date

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

News Conference News SCAI 2017

#SoMe for #SciComm? Cardiologists See Value in Social Media, With Some Caveats

L.A. McKeown

May 10, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

Podcast TCTMD Talking Points

Episode 19: Pragmatic Clinical Trials and the Road Ahead

May 03, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

News Daily News

Absorb BVS Use Restricted in Europe

Michael O'Riordan

April 06, 2017

News Daily News

Crowdfunding Medical Care Poses Ethical Quandaries for Physicians

Yael L. Maxwell

April 05, 2017

News Daily News

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Todd Neale

April 04, 2017

News Daily News

Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows

Michael O'Riordan

March 31, 2017

News Daily News

Only One Third of US States Require AEDs in Schools

Michael O'Riordan

March 28, 2017

News Daily News

Hospital-Level PCI Volume May Not Have a Strong Influence on Outcomes, UK Study Suggests

Todd Neale

March 27, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

Advertisement

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Boston Scientific Scraps Biodegradable Scaffold Program

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Betrixaban Approved for Prevention of VTE

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

#SoMe for #SciComm? Cardiologists See Value in Social Media, With Some Caveats

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Episode 19: Pragmatic Clinical Trials and the Road Ahead

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Absorb BVS Use Restricted in Europe

Crowdfunding Medical Care Poses Ethical Quandaries for Physicians

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows

Only One Third of US States Require AEDs in Schools

Hospital-Level PCI Volume May Not Have a Strong Influence on Outcomes, UK Study Suggests

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content